| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 27 Jan 2026 | 50 | 31% | 29% | 40% | 5% |
| 01 Jan 2025 - 30 Jun 2025 | 29 Jul 2025 | 50 | 35% | 22% | 43% | 8% |
| 01 Jul 2024 - 31 Dec 2024 | 31 Jan 2025 | 45 | 39% | 26% | 35% | 7% |
| 01 Jan 2024 - 30 Jun 2024 | 30 Jul 2024 | 54 | 32% | 19% | 49% | 8% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 53 | 35% | 24% | 41% | 6% |
| 01 Jan 2023 - 30 Jun 2023 | 27 Jul 2023 | 55 | 32% | 21% | 47% | 9% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 53 | 30% | 32% | 38% | 9% |
| 01 Jul 2021 - 31 Dec 2021 | 28 Jan 2022 | 50 | 37% | 40% | 23% | 6% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 52 | 29% | 52% | 20% | 8% |
| 01 Jan 2020 - 30 Jun 2020 | 29 Jul 2020 | 56 | 28% | 16% | 56% | 13% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 58 | 25% | 17% | 58% | 11% |
| 01 Jan 2019 - 30 Jun 2019 | 30 Jul 2019 | 68 | 10% | 21% | 69% | 17% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 56 | 31% | 24% | 45% | 18% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 71 | 10% | 13% | 77% | 37% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Qualifying contracts for this entity contain a number of different payment periods: • Immediate • 30 days • 60 days • 45 days • 30 days and 5th of the following month • 60 days and 5th of the following month Payments are made from date of receipt of invoice.
Were there any changes to the standard payment terms in the reporting period?
Standard 30-day terms for SMEs were introduced in place of a previous offer of 30 day terms upon application by the vendor.
Any other information about payment terms
1) Statistics Reported: Intercompany invoices and performance have been excluded from reported statistics as these are generally wholly owned group companies and would distort performance if included. 2) Payment terms for SMEs and 'Paid on Time' monitoring: Preferential payment terms of 30 days are put in place for vendors that are confirmed as SMEs (Small and Medium Enterprises). We closely monitor our KPIs on a weekly basis to ensure that vendors (including SMEs) are paid on time. Corrective actions are taken to remedy any late payment issues where these are within the entity’s control.
Maximum contractual payment period agreed
60
We offer our suppliers the following support and service: • Enquiries and complaints can be logged through our Helpdesk support system (mail or telephone). Issues are often related to incorrect invoice submission, payment terms are not as per contract, PO details are wrong / nonexistent etc. Key performance metrics are monitored for quality of Helpdesk support. • Our Supplier web pages also include details and a link to our Speak Up channels that enable concerns to be raised, including channels managed independently of GSK and the option to doso anonymously, although naturally it helps in resolving matters if we know as much as possible about the issue and complainant. • We have invested in Customer Relationship Management (CRM) to ensure effective and independent supplier follow up and support to our suppliers raising issues.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
VIIV HEALTHCARE UK LIMITED is a pharmaceutical company that focuses on providing innovative treatments for HIV. The company was founded in 2009 and is a joint venture between GlaxoSmithKline, Pfizer, and Shionogi.
The company's sustainability program is centered around three key pillars: people, planet, and partnerships. VIIV HEALTHCARE UK LIMITED is committed to promoting diversity and inclusion within its workforce and ensuring a safe and healthy work environment. They also strive to reduce their environmental impact by implementing sustainable practices in their operations and supply chain. The company also collaborates with various organizations and communities to support HIV education, prevention, and treatment.
VIIV HEALTHCARE UK LIMITED offers a range of products and services for the management of HIV, including antiretroviral therapies and support programs for patients. The company also conducts research and development to continuously improve their treatments and find new solutions for HIV.
The key people at VIIV HEALTHCARE UK LIMITED include the CEO, Deborah Waterhouse, and the company's board of directors. They are dedicated to the company's mission of providing effective and accessible treatments for HIV.
To contact VIIV HEALTHCARE UK LIMITED, individuals can visit their website at www.viivhealthcare.com or reach out to their registered office at 980 Great West Road, Brentford, Middlesex, TW8 9GS. Overall, VIIV HEALTHCARE UK LIMITED is a leading player in the fight against HIV, with a strong commitment to sustainability and improving the lives of those affected by the disease.
Proud of your payment record? Show your live score on your own site:
<iframe src="https://paymentcheck.co.uk/badge/06990358" width="240" height="72" style="border:0" title="PaymentCheck Score" loading="lazy"></iframe>